All Episodes
Treating Blood Cancers — 122 episodes
Strengthening Bereavement Care in Oncology
Waldenström macroglobulinemia: What to Know in Practice
Mastocytosis: What Clinicians Need to Know
CAR-T Today and Tomorrow: Clinical Decision-Making and Patient Support
Optimizing HSCT in Blood Cancers
Clinical Strategies for Supporting Couples, Care Partners, and Families in Oncology Care
Driving Progress in AML
Redefining Normal: Clinical Insights for Healthcare Professionals Supporting Survivors After Treatment
Optimizing Outcomes in Myeloma
Strategies to Navigate Expanded Access (Compassionate Use) in Treating Pediatric Oncology
What’s New and What’s Next in CLL
Guiding Fertility Care for Adolescents and Young Adults
Building Resilience: Burnout & Compassion Fatigue Tools for HCPs
Key Insights from Attending ASH 2025
Delivering Equitable Cancer Care: What Every Healthcare Professional Should Know
Hairy Cell Leukemia: Strategies for Improved Patient Outcomes
Managing CML: What HCPs Need to Know
Understanding MRD: Insights for clinical practice and patient care
Pediatric Acute Leukemias: Focus on clinical trials for treatment
Charting the Course of ALL: From Diagnosis to Advances
Strategies and Advances in AML
Advancing Care in Myeloproliferative Neoplasms (MPNs)
A Collaborative Approach to Survivorship Care
MDS: Patient-Centered Approaches to Diagnosis and Treatment
Optimizing Care for Pediatric Blood Cancer
Navigating Complex and Challenging Cases in Myeloma
Beyond Burnout: Strategies for Empowering Healthcare Professionals
Key Strategies for HCPs: Supporting Caregivers and Care Partners
CAR-T in 2025: Advancements and the Road Ahead
Exploring Cutaneous T-Cell Lymphoma
Highlights from Attending ASH 2024
Advancing Treatment Strategies: The Role of Bispecific Antibodies in Lymphoma
Understanding Mental Health in Cancer Survivorship
What’s New in Chronic Lymphocytic Leukemia (CLL)?
The Role of the Healthcare Team in Biomarker Testing
Decoding Medicare for Healthcare Professionals
Treating Hodgkin Lymphoma: What HCPs Need to Know
Highlights from Attending the 2024 Society of Hematologic Oncology (SOHO) Annual Meeting
Unpacking Mantle Cell Lymphoma
Clinical Perspectives on Hereditary Myeloid and Hematologic Disorders
Navigating Adult Survivorship Care
Managing Oral and Dental Complications in Cancer Treatment
Exploring Survivorship Needs of Older Adults
Strategic Approaches to Pediatric and AYA Survivorship Care
Insights and Updates on Navigating the AML Landscape
CAR T-cell Therapy in 2024
Supporting Healthcare Professionals to Reduce Burnout
Creating a Roadmap for Adult Survivorship Care
Highlights from attending the 2023 ASH Annual Meeting
A Conversation on Transplantation
Addressing Barriers & Disparities for Hispanic/Latinx Blood Cancer Survivors Throughout the Care Journey
Survivorship Care of Older Adults: Addressing the Unique Needs
Measuring Quality of Life in Adolescent and Young Adult Cancer Care
Supporting Adolescent and Young Adult (AYA) Survivors
Understanding and Treating LGBTQI+ Patients with Cancer
Chronic Myeloid Leukemia: What HCPs Need to Know
2022 ASH Annual Meeting: Highlights from the Perspective of a Conference Attendee
Understanding Waldenström Macroglobulinemia
CAR T-cell Therapy in Review 2022: Updates in Treatment
Shared Decision Making with Your Patients Diagnosed with a Chronic Leukemia: Part II
AML: Insights, Updates, and Takeaways
Insights from Attending the 2022 Society of Hematologic Oncology (SOHO) Annual Meeting
What’s New in the Treatment of BPDCN?
Mastocytosis: Insight into a Rare Blood Cancer
The Role of Genomics in Treating Blood Cancers
Insights into Pediatric Survivorship for the HCP
PedAL: First-of-Its-Kind Global Master Clinical Trial for Pediatric Acute Leukemia
The Role of the Primary Care Physician in Treating Chronic Blood Cancers: Focus on Myeloma
CAR T-cell Therapy in 2022: What You Need to Know Part II
Everything You Need to Know About Cutaneous T-cell Lymphoma
A Deep Dive into Myelofibrosis
Shared Decision Making with Your Patients Diagnosed with a Chronic Leukemia: Part I
CAR T-cell Therapy in 2022: What You Need to Know
Highpoints from Attending the 2021 American Society of Hematology Conference
Updates on COVID-19 in Patients with Blood Cancer
A Conversation on Adult Survivorship
The Advanced Practice Provider’s Role in Treating Newly Diagnosed Patients with Myeloma
The Physician’s Role in Treating Newly Diagnosed Patients with Myeloma
Clinical Trials: A Healthcare Professional’s Perspective
Wearing Two Hats: Supporting the Childhood Cancer Patient as Nurse & Parent
Addressing Healthcare Disparities in Cancer Care
T-cell Lymphoma: A Discussion on Treatment and Patient Support
A Discussion on MRD: Practical Information for Providers
A Deeper Dive into Cancer Genomics
The Pharmacist’s Role on the Blood Cancer Treatment Team
A Conversation on Multiple Myeloma with Edward Stadtmauer, MD
The COVID-19 Vaccine and Your Patient with Cancer
Managing Treatment for Patients with Relapsed/Refractory Lymphoma
What’s New in Treatment for Acute Myeloid Leukemia (AML)
Progress in the Treatment of Follicular Lymphoma
Current Applications of Cancer Genomics: Focus on CLL
Supporting LGBTQI Cancer Patients
A Deeper Dive into MRD: A Conversation with Gail Roboz, MD
Communicating with Caregivers: Strategies for HCPs
Communicating with the Young Adult with Blood Cancer
Facilitating the Learning Experience of Children and AYAs During and After Cancer Treatment
Myelodysplastic Syndromes (MDS): Caring for Low and High-Risk Patients
Treating Children with Cancer during the COVID-19 Pandemic
CML: Treatment Considerations and Survivorship Challenges
Understanding the Complexities of Myeloproliferative Neoplasms
COVID-19: What Healthcare Professionals Need to Know
The Role of the PA and Nurse in Treating Patients during the COVID-19 Pandemic
Insights in to Transplantation with Dr. Fredrick Appelbaum
Disparities in Cancer Care: Focus on Myeloma
Long-Term and Late Effects of Childhood Cancer: A Conversation on Survivorship
Compassion Fatigue in Cancer Care
Mantle Cell Lymphoma: Disease and Treatment Updates
Treatment Considerations for NHL as a Chronic Disease
CAR T-cell Therapy: The Nurse’s Role in Treating Patients
A Discussion on the Future of CAR T-cell Therapy with Dr. Frederick Locke
CAR T-cell Therapy: A Deeper Dive into Adverse Effects and Financial Toxicities
CAR T-cell Therapy: A 60,000 Foot View
Caring for the patient with CLL with Susan O’Brien, MD
An Overview of the Beat AML® Master Trial: Pioneering Treatment Options and Patient Services
Unique Challenges for Young Adult Cancer Survivors: What You Should Know
Hearing the Patient’s Voice: A Discussion on Myelodysplastic Syndrome with a Survivor, a Caregiver, and a Physician
A Conversation on AL Amyloidosis with Dr. Raymond Comenzo, MD
Childhood Blood Cancers: Focus on Acute Lymphoblastic Leukemia with Dr. Lewis Silverman, MD
Part II of Understanding Multiple Myeloma
Part I of Understanding Multiple Myeloma
A Conversation on AML: Diagnosis and Treatment
BPDCN – Expert Insight Into a Rare Blood Cancer